to t h e re a d e rs ( Scopus ® ), about 70% of which were original articles, 13% were case reports and letters, and 8% were editorials, mostly submitted from abroad-India, USA, Egypt, Canada, and UK. The Journal's H index is currently 10; 13 articles have so far received 10 or more citations (Scopus ® ). Two articles, "post-traumatic stress disorder" (cited 39 times), and "high-field MRI and mercury release from dental amalgam fillings" (cited 27 times) received the highest number of citations. 1, 2 Although the Journal does not currently have an official impact factor, as reported by Thomson Reuters' Journal Citation Report, its unofficial impact factor is about 1.5 (based on SCImago) 3 that reaffirms the quality of our Journal.
The number of multicenter/multinational studies we have received (and published) is increasing. I think part of this increase is atributted to our success at being indexed in prestigious indexing systems with subsequent increased visibility and in part a result of an improved manuscript triage process. Our editors evaluate and discuss all the submitted manuscripts in-office and reject 30% to 50% of them within a week of submission. This rejection rate helps us to concentrate on more appropriate manuscripts; it is also beneficial to authors, who learn about our decision earlier and can thus submit their manuscript to a more appropriate journal. Furthermore, it decreases the burden on our always-busy reviewers.
What is next? We have published some manuscripts online before publishing them in print. We are pursuing this strategy to inform our readers of important articles sooner. We are also publishing more supporting data online only (as Web Extra), such as search strategies of systematic reviews and questionnaires. We plan to focus more on articles presenting new techniques and methods rather than simply reporting the prevalence of certain local diseases. Currently, we accept less than 10% of the manuscripts submitted for publication. Therefore, to publish in The IJOEM, please do not send us your good articles; send us your best ones! Farrokh Habibzadeh, MD, Editor and Founder, The IJOEM
